It was reported that this patient with this cardiac resynchronization therapy defibrillator (crt-d) experienced ventricular fibrillation (vf) after anti-tachycardia pacing (atp) therapy was delivered.Then the shock therapy was delivered.However, the shock therapy was unable to covert the vf.Which led to the patient experiencing cardiac arrest.Subsequently, the physician opted to deliver an external shock.An x-ray was performed and the lead was found to be in the same position as the initial implant.It was noted that the patient has an underlying condition, which is being controlled through medication.At this time, the patient is hospitalized and no additional adverse patient effects were reported.The product remains in service.
|